Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.

about

Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study Group.Plerixafor in poor mobilizers with non-Hodgkin's lymphoma: a multi-center time-motion analysis.Impact of CXCR4/CXCL12 Blockade on Normal Plasma Cells In Vivo.

P2860

Q47967442-68CD4C27-319E-45CE-941D-AACBC1E52C8A Q48097743-8FCDD3F7-34CF-4B2C-9CC4-EE0DD6FADADD Q48196380-EBB4855F-7694-49AE-AEF8-E82E0E3B6DB6

P2860

Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.

Item

http://www.wikidata.org/entity/Q40490106

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Evaluating the use of plerixaf ...... lysis of the PHANTASTIC trial.

@en

type

Item

label

Evaluating the use of plerixaf ...... lysis of the PHANTASTIC trial.

@en

prefLabel

Evaluating the use of plerixaf ...... lysis of the PHANTASTIC trial.

@en

P1476

Evaluating the use of plerixaf ...... lysis of the PHANTASTIC trial.

@en

P2093

Alan Haycox

http://www.w3.org/2001/XMLSchema#string

Barbara Braithwaite

http://www.w3.org/2001/XMLSchema#string

Claire McLeod

http://www.w3.org/2001/XMLSchema#string

Jack O Clark

http://www.w3.org/2001/XMLSchema#string

Joanne Bell

http://www.w3.org/2001/XMLSchema#string

Rachel Houten

http://www.w3.org/2001/XMLSchema#string

Richard E Clark

http://www.w3.org/2001/XMLSchema#string

Sarah Richards

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies

Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation

Time to look beyond one-year mortality in critically ill hematological patients?

European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European Consortium of stem cell mobilization.

Plerixafor is superior to conventional chemotherapy for first-line stem cell mobilisation, and is effective even in heavily pretreated patients

Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the prospective PREDICT trial

Plerixafor for mobilization of blood stem cells in autologous transplantation: an update.

Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation.

Role of hematopoietic stem cell transplantation in multiple myeloma.

P304

434-442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCA.21433

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Antony Paul Martin

P577

2015-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26415895

http://www.w3.org/2001/XMLSchema#string

Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.

about

P2860

P2860

Evaluating the use of plerixafor in stem cell mobilisation - an economic analysis of the PHANTASTIC trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698